Canakinumab for Atherosclerotic Disease
N Engl J Med
.
2018 Jan 11;378(2):196-7.
doi: 10.1056/NEJMc1714635.
Authors
Thorsten Derlin
1
,
Frank M Bengel
1
Affiliation
1
Hannover Medical School, Hannover, Germany derlin.thorsten@mh-hannover.de
PMID:
29322754
DOI:
10.1056/NEJMc1714635
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal*
Antibodies, Monoclonal, Humanized
Atherosclerosis*
Humans
Substances
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
canakinumab